These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25929909)

  • 41. Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies.
    Darrington DL; Vose JM; Anderson JR; Bierman PJ; Bishop MR; Chan WC; Morris ME; Reed EC; Sanger WG; Tarantolo SR
    J Clin Oncol; 1994 Dec; 12(12):2527-34. PubMed ID: 7989926
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease.
    van Leeuwen FE; Klokman WJ; Stovall M; Dahler EC; van't Veer MB; Noordijk EM; Crommelin MA; Aleman BM; Broeks A; Gospodarowicz M; Travis LB; Russell NS
    J Natl Cancer Inst; 2003 Jul; 95(13):971-80. PubMed ID: 12837833
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Occupational, dietary, and other risk factors for myelodysplastic syndromes in Western Greece.
    Avgerinou C; Giannezi I; Theodoropoulou S; Lazaris V; Kolliopoulou G; Zikos P; Alamanos Y; Leotsinidis M; Symeonidis A
    Hematology; 2017 Aug; 22(7):419-429. PubMed ID: 28102107
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Therapy-related hematologic neoplasias after breast cancer. Epidemiologic, etiologic and cytogenetic aspects and new risk factors according to published data and own results].
    Haase D; Hanf V; Schulz T
    Med Klin (Munich); 2004 Sep; 99(9):506-17. PubMed ID: 15372180
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Leukemia incidence following primary breast carcinoma treatment.
    Kaplan HG; Malmgren JA; Atwood M
    Cancer; 2004 Oct; 101(7):1529-36. PubMed ID: 15378478
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A population-based study of survival in patients with secondary myelodysplastic syndromes (MDS): impact of type and treatment of primary cancers.
    De Roos AJ; Deeg HJ; Davis S
    Cancer Causes Control; 2007 Dec; 18(10):1199-208. PubMed ID: 17823848
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Etiological factors of myelodysplastic syndromes].
    Nisse C
    Pathol Biol (Paris); 1997 Sep; 45(7):539-44. PubMed ID: 9404476
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Therapy-induced myelodysplasia and secondary leukaemia.
    Frisch B; Bartl R; Chaichik S
    Scand J Haematol Suppl; 1986; 45():38-47. PubMed ID: 3457445
    [No Abstract]   [Full Text] [Related]  

  • 49. Smoking and alcohol and subsequent risk of myelodysplastic syndromes in Japan: the Japan Public Health Centre-based Prospective Study.
    Ugai T; Matsuo K; Sawada N; Iwasaki M; Yamaji T; Shimazu T; Sasazuki S; Inoue M; Kanda Y; Tsugane S;
    Br J Haematol; 2017 Sep; 178(5):747-755. PubMed ID: 28714213
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Moderate increase of secondary hematologic malignancies after myeloablative radiochemotherapy and autologous stem-cell transplantation in patients with indolent lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group.
    Lenz G; Dreyling M; Schiegnitz E; Haferlach T; Hasford J; Unterhalt M; Hiddemann W
    J Clin Oncol; 2004 Dec; 22(24):4926-33. PubMed ID: 15611507
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predictors of outcome following myeloablative allo-SCT for therapy-related myelodysplastic syndrome and AML.
    Nevill TJ; Hogge DE; Toze CL; Nantel SH; Power MM; Abou Mourad YR; Song KW; Lavoie JC; Forrest DL; Barnett MJ; Shepherd JD; Nitta JY; Wong S; Sutherland HJ; Smith CA
    Bone Marrow Transplant; 2008 Nov; 42(10):659-66. PubMed ID: 18679372
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Second malignancies following treatment in non-Hodgkin's lymphoma.
    Ellis M; Lishner M
    Leuk Lymphoma; 1993 Mar; 9(4-5):337-42. PubMed ID: 8348069
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alcohol use is not a significant contributor to myelodysplastic syndromes.
    Duffy EA; Nguyen PL; Cioc A; Warlick E; Roesler MA; Poynter JN
    Cancer Causes Control; 2020 Jun; 31(6):549-557. PubMed ID: 32285234
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of comorbidities at diagnosis predicts outcome in myelodysplastic syndrome patients.
    Breccia M; Federico V; Latagliata R; Mercanti C; D'Elia GM; Cannella L; Loglisci G; Salaroli A; Santopietro M; Alimena G
    Leuk Res; 2011 Feb; 35(2):159-62. PubMed ID: 20594593
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Outcome of patients who develop acute leukemia or myelodysplasia as a second malignancy after solid tumors treated surgically or with strategies that include chemotherapy and/or radiation.
    Abdelhameed A; Pond GR; Mitsakakis N; Brandwein J; Chun K; Gupta V; Kamel-Reid S; Lipton JH; Minden MD; Schimmer A; Schuh A; Yee K; Messner HA
    Cancer; 2008 Apr; 112(7):1513-21. PubMed ID: 18286528
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study.
    Takahashi K; Wang F; Kantarjian H; Doss D; Khanna K; Thompson E; Zhao L; Patel K; Neelapu S; Gumbs C; Bueso-Ramos C; DiNardo CD; Colla S; Ravandi F; Zhang J; Huang X; Wu X; Samaniego F; Garcia-Manero G; Futreal PA
    Lancet Oncol; 2017 Jan; 18(1):100-111. PubMed ID: 27923552
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Therapy-related leukemia and myelodysplastic syndrome in chronic lymphocytic leukemia.
    Robertson LE; Estey E; Kantarjian H; Koller C; O'Brien S; Brown B; Keating MJ
    Leukemia; 1994 Dec; 8(12):2047-51. PubMed ID: 7807993
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Obesity over the life course and risk of acute myeloid leukemia and myelodysplastic syndromes.
    Poynter JN; Richardson M; Blair CK; Roesler MA; Hirsch BA; Nguyen P; Cioc A; Warlick E; Cerhan JR; Ross JA
    Cancer Epidemiol; 2016 Feb; 40():134-40. PubMed ID: 26720913
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The long term risk of myelodysplastic syndromes among anemia patients: a population-based study.
    Meytes D; Chodick G; Shalev V; Porath A
    Leuk Res; 2012 Mar; 36(3):327-30. PubMed ID: 22142797
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk of cancer among HIV-infected patients from a population-based nested case-control study: implications for cancer prevention.
    Chen CH; Chung CY; Wang LH; Lin C; Lin HL; Lin HC
    BMC Cancer; 2015 Mar; 15():133. PubMed ID: 25885746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.